Post by
skys1 on Jan 28, 2022 3:18pm
FINALLY AFTER ALL THESE YEARS, WE ARE FINALLY IN GOOD HANDS!
I don't know how many of you have seen Dr Vera's resume, but it surely is the most impressive I have seen. The fact that such an accomplished, experienced pro would take a look at TLT's ACT and it's potential and want in, is very assuring. IMO, the one void in TLT's resume was the lack of an experienced, accomplished Director of Clinical Development to develope and govern the trials and deal with the FDA etc. Now that we have her expertise I expect at least three of the following four accomplishments this year. BTD, continued positive trial results, an additional new trial for another indication, and lastly some type of deal on funding, licensing or something along commercial developement lines. For sure, I expect the share price to be substantially above where it is now. I believe people are now starting to see this potential and while the rest of the market is tanking, TLT remains near it's yearly high.
Comment by
StevenBirch on Jan 28, 2022 3:30pm
I agree Skys, with that resume it would seem like "an additional new trial for another indication" is a slamdunk especially given the timing of her coming on board - it's like a precursor of what is to come. Behind the scenes and in between updates they obviously like what they see. People waiting for confirmation from a news release will have to pay a much steeper price.
Comment by
Longholder99 on Jan 28, 2022 4:47pm
Agree Skys1. She wouldnt sign up with a loser. Vera doesnt seem like someone who messes around and is here for a reason.
Comment by
Legit62 on Feb 01, 2022 9:49am
she was a sign of faith in this company, our time is now